What Risk Hormones? Conflicting Studies Reveal Problems in Pinning Down Breast Cancer Risks

By Seachrist, Lisa | Science News, August 5, 1995 | Go to article overview

What Risk Hormones? Conflicting Studies Reveal Problems in Pinning Down Breast Cancer Risks


Seachrist, Lisa, Science News


Women contemplating postmenopausal hormone therapy have a right to be confused. Scientists report one week that taking hormones raises the likelihood of developing breast cancer. A few weeks later, another study indicates that they don't.

The controversy surrounding whether hormone replacement therapy (HRT) makes women more susceptible to breast cancer leaves them trying to decide for themselves whether the benefits of therapy outweigh their individual risks--which may depend on factors such as reproductive and family history. Amid the current scientific uncertainty, it's like betting all your money on a horse without knowing the odds for the race.

Estrogen-only preparations of postmenopausal HRT undoubtedly offer substantial protection against heart disease and osteoporosis. In fact, comparing the use of estrogen-only HRT to no therapy shows that "HRT benefits outweigh the risks in terms of basic deaths from any disease," says Louise Brinton of the National Cancer Institute in Bethesda, Md.

But that protection may come at a price: Endometrial cancer is a side effect of estrogen-only therapy. What's more, estrogen-only HRT appears to increase the risk of breast cancer, especially with long-term use.

Results of a recent study indicate that adding progestin (synthetic progesterone) to estrogen protects against endometrial cancer without eliminating estrogen's beneficial cardiac effects. Scientists then wondered whether the addition of progestin would ameliorate or amplify estrogen's effect on the breast. Harvard University researchers led by Walter Willett seemed to have answered that question when they reported in the June 15 New England Journal of Medicine that long-term use of HRT increases the risk of developing breast cancer, regardless of formulation (SN: 6/17/95, p.375).

Yet just 4 weeks later, a team led by Janet L. Stanford at the Fred Hutchinson Cancer Research Center in Seattle reported in the Journal of the American Medical Association that women who took the estrogen-plus-progestin formulation did not face an increased risk of breast cancer.

These conflicting reports left women even more confused about the prudence of taking HRT, whether for the rest of their lives or just a short time. For the scientific community, the wide discrepancy between the reports illustrates the difficulty of assessing moderate risk factors associated with disease and the perils of comparing very different epidemiological studies.

Unlike the case of lung cancer, which strikes smokers 10 to 20 times more often than nonsmokers, pinning down risk factors for developing breast cancer hasn't been easy. With the exception of the rare and not able BRCA1 and BRCA2 genes, which lead to breast cancer for 85 out of every 100 carriers, no one risk factor proclaims dire consequences.

Brinton maintains that "at best we can only explain 50 percent of all cases of breast cancer with any [identifiable] risk factors." This fact has led Willett to note that "simply being a woman in America places you at risk."

Approximately one out of every eight women in the United States will develop breast cancer during her lifetime (SN: 7/31/93, p.77). The American Cancer Society estimates that in 1995, doctors will diagnose 182,000 U.S. women and 1,400 U.S. men with breast cancer. "Quite obviously there is something different about being a women . . . that puts you at risk for breast cancer," says Barbara Hulka of the University of North Carolina at Chapel Hill School of Public Health.

The most obvious difference between men and women is the sex hormones coursing through their bodies. Estrogen and progesterone, the primary female hormones, stimulate breast cells to grow and divide. Studies in animals show that the two hormones spur the growth of breast cancers. And studies have found that women whose ovaries were removed early in life have markedly reduced rates of breast cancer, presumably because they lack ovarian estrogen and progesterone. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

What Risk Hormones? Conflicting Studies Reveal Problems in Pinning Down Breast Cancer Risks
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.